▲ Peaking
Health
GLP-1 Side Effects vs. Benefits: Real Patient Experiences
Recent reporting examines the available evidence regarding weight-loss drugs and bone health.
Weight-Loss Drugs
34 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
Is my GLP-1 safe? What to know about FDA's crackdown on copycat drugs
FDA moves to curb bulk compounding of GLP‑1 weight‑loss drugs as legal action hits telehealth firm HIMS
◼ Archived
Health
The Difficulty of Diagnosing Anorexia in the GLP-1 Era
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Popular weight loss drugs linked to a surprising fingernail problem
Popular weight loss medications face new scrutiny as coverage connects them to unusual nail and hair complications.
◼ Archived
Health
Some who take GLP-1s are suffering serious side effects, but it's unclear how often
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Probing the many benefits of GLP-1 receptor agonists
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
GLP-1 Users Report More Nail Detachments
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Hair Loss Was Just the Start. Ozempic Users Are Also Reporting Nail Trouble
Recent findings indicate that GLP-1 weight-loss drugs can potentially lead to nail loss, expanding known side effects.
◼ Archived
Health
New study suggests possible connection between GLP-1s and hair loss in men
Recent studies link popular GLP-1 weight-loss drugs to surprising physical side effects including hair loss and nail troubles.
◼ Archived
Health
Popular weight-loss drugs may play surprising role in cancer outcomes
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Some GLP-1 companies facing lawsuits over vision loss. What to know
GLP-1 weight-loss drugmakers face patient lawsuits alleging sudden vision loss as doctors issue health warnings.
◼ Archived
Business
Eli Lilly is breaking ground in Houston on a facility planned for 2030
Eli Lilly plans a 2030 groundbreaking in Houston as weight-loss drug developers line up to tap a lucrative and increasingly competitive market.
◼ Archived
Health
🔮 fades ✗
Popular GLP-1 drugs may trigger a rare, life-threatening brain disorder: study
Recent studies suggest a link between popular GLP-1 weight-loss medications and severe neurological and psychological risks.
◼ Archived
Health
🔮 fades ✓
Glucagon-Like Peptide-1 Receptor Agonists for Obstructive Sleep Apnea A Review
Recent medical reviews examine how popular weight-loss drugs could transform the clinical treatment of obstructive sleep apnea.
◼ Archived
Health
🔮 fades ✓
GLP-1 weight-loss drugs show promise for sleep apnea
New research indicates GLP-1 weight-loss medications like Mounjaro and Zepbound may offer therapeutic benefits for the one billion people with sleep apnea.
◼ Archived
Health
🔮 fades ✗
Cravings ‘like heroin withdrawal’: what happens when weight-loss drugs don’t work?
Growing concerns emerge over the 'Ozempidemic' as users report intense cravings and safety risks associated with GLP-1 weight-loss medications.
◼ Archived
Health
🔮 fades ✓
More children under 12 in US are being prescribed weight-loss drugs, study finds
Recent studies reveal a surge in US children under 12 being prescribed weight-loss drugs like GLP-1.
◼ Archived
Health
🔮 fades ✓
Scientists Flag Shocking New Concern for Men on GLP-1 Drugs
A new study suggests a genetic link between the use of GLP-1 weight-loss medications and increased hair loss risks for certain men.
◼ Archived
Health
🔮 fades ✓
Weight loss drugs could see men losing more than just fat
New reports suggest popular GLP‑1 weight‑loss drugs may trigger male pattern baldness, sparking medical and public‑interest scrutiny.
◼ Archived
Health
🔮 fades ✓
GLP-1 weight loss drugs effective even at low starter doses
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Ozempic may help people with serious mental health condition: study
Ozempic, a popular weight‑loss drug, is now being linked to benefits for serious mental illnesses such as bipolar disorder.
◼ Archived
Health
🔮 fades ✗
Ozempic is not just a weight-loss story anymore
Recent discussions highlight a shift in the narrative surrounding weight-loss drugs, focusing on gender dynamics and the desire for medical privacy.
◼ Archived
Health
🔮 fades ✗
Coroner links teenage student’s death to weight-loss drug Mounjaro
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Starbucks is ending GLP-1 coverage for weight loss as employer costs climb
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades
Pharmacists Warn About Diet on Weight Loss Drugs
Pharmacists and health experts are urging GLP-1 weight loss medication users to prioritize specific nutritional strategies to mitigate side effects.
◼ Archived
Health
🔮 fades
Hair loss with GLP-1 drugs is rare, but real, studies find
New research suggests a link between GLP-1 weight-loss medications and an increased risk of hair loss, though the occurrence is described as rare.
◼ Archived
Health
🔮 fades
Weight loss drugs linked to increased risk of hair loss, researchers say
New research links GLP-1 weight-loss medications like Ozempic and Mounjaro to an increased risk of hair loss in patients.
◼ Archived
Business
🔮 holds
Novo sues Lilly, claiming misleading ads in weight-loss drug battle
Novo Nordisk has filed a lawsuit against Eli Lilly over allegations of deceptive and misleading advertising regarding GLP-1 weight-loss drugs.
◼ Archived
Health
🔮 fades
GLP-1’s Reduce Binge Eating Symptoms
Emerging research suggests GLP-1 receptor agonists may provide a promising treatment for binge eating disorder and emotional eating symptoms.
◼ Archived
Business
🔮 fades
What older adults need to know before taking a GLP-1 medication to lose weight
Recent reporting examines why Medicare policy fails to transform the market prospects for weight-loss drug manufacturers.
◼ Archived
Health
🔮 fades
As weight loss drugs like Ozempic spread, Louisiana doctors, researchers help answer big questions
GLP-1 weight‑loss drugs spark a wave of research, clinical guidance and market buzz as they expand beyond obesity treatment.
◼ Archived
Health
🔮 fades
GLP-1 drugs linked to major drop in pancreatic, colorectal cancer risk
11 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades
Weight loss drugs slash risk of 4 types of cancer by 50% or more, study finds
New study data indicates that GLP-1 weight loss medications are associated with a significant reduction in the risk of developing four specific cancer types.
◼ Archived
Health
🔮 fades
Ozempic Users Are Skimping Out on Exercise, Study Finds
New research indicates that patients taking GLP-1 weight loss drugs are reducing their physical activity levels.